Old Web
English
Sign In
Acemap
>
authorDetail
>
Karen Auditore-Hargreaves
Karen Auditore-Hargreaves
Immunology
Doubling time
Pretargeted Radioimmunotherapy
Cancer research
Cancer
2
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.
2003
Clinical Cancer Research
Scott S. Graves
Erica Dearstyne
Yukang Lin
Yuting Zuo
James Sanderson
Jody Schultz
Anastasia Pantalias
David Gray
Don B. Axworthy
H. Mark Jones
Karen Auditore-Hargreaves
Show All
Source
Cite
Save
Citations (50)
Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway.
2002
Immunology and Cell Biology
Tatsue Monji
Jerilyn Tynes Petersons
Narinder K Saund
Slavica Vuckovic
Derek N. J. Hart
Karen Auditore-Hargreaves
Grant Risdon
Show All
Source
Cite
Save
Citations (5)
1